Emerging and Traditional Risk Factor Profiles in Young Patients With Cardiomyopathy
Despite the increasing incidence of heart failure (HF) among younger ( (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - July 1, 2023 Category: Cardiology Authors: M. Zaheen, J. Kaur, H. Mohammed Abdul, G. Gan, T. Tan Source Type: research

Examining the Landscape of Surrogate Outcomes in Clinical Trials of Heart Failure With Preserved Ejection Fraction (HFpEF) Patients: A Narrative Review
Heart failure with preserved ejection fraction (HFpEF) accounts for>50% of heart failure and has few proven therapies. Clinical outcome trials are the gold standard to evaluate new therapies in heart failure. These are often large, long, labour-intensive, and expensive. There is a need to identify robust surrogate outcomes that correlate with clinical outcomes in HFpEF. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - July 1, 2023 Category: Cardiology Authors: J. Lin, A. Perkovic, C. Arnott Source Type: research

Exploring and Predicting Heart Failure Risk and Progression Using Electronic Medical Records
Improving outcomes in the heart failure epidemic requires a better understanding of heart failure hospitalisation and progression of the syndrome. Readmission and death are highly prevalent in the hospitalised heart failure patient population, with 30-day readmission rates of around 20%, over half of the patients readmitted within a year, and an estimated 5-year mortality rate of 75%. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - July 1, 2023 Category: Cardiology Authors: L. Huberts Source Type: research

Feasibility, Safety, and Efficacy of Spot Urinary Sodium-Guided Titration of Intravenous Diuretic Therapy in Acute Heart Failure: A Randomised Controlled Trial
Spot urinary sodium concentration (UNa) is advocated in guidelines to assess diuretic response and titrate dosage in acute heart failure (AHF) based solely on expert opinion. This randomised trial was performed to investigate the feasibility, safety, and efficacy of this approach. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - July 1, 2023 Category: Cardiology Authors: M Khorramshahi Bayat, W. Chan, K. Hay, S. McKenzie, I. Ranasinghe Source Type: research

Five-Year Prescription Trends of ARNI in HFrEF: A Single-Centre Experience
This study aimed to evaluate the temporal trends in ARNI prescription and any changes in short- or medium-term mortality rates at the Cardiology department of Northern Hospital, Melbourne, Australia. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - July 1, 2023 Category: Cardiology Authors: A. Patel, A. Dawson, N. Sharma Source Type: research

Gender Differences in the Evolution of Echocardiographic HFpEF Characteristics Through Age Deciles: Is Menopause an Inflection Point?
This study aimed to compare left ventricular (LV) echocardiographic parameters between gender, through age deciles. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - July 1, 2023 Category: Cardiology Authors: K. George, J. Gorcilov, T. Hecker, J. Eng-Frost, C. De Pasquale Source Type: research

Giant Cell Myocarditis as a Rare but Important ST-Elevation Myocardial Infarction Mimic: A Case Report
Giant cell myocarditis (GCM) is a rare, often rapidly progressive form of myocarditis characterised by frequent progression to refractory heart failure, cardiogenic shock, ventricular arrhythmia, and need for cardiac transplantation. However, very few reports highlight GCM as a potential ST-elevation myocardial infarction (STEMI) mimic. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - July 1, 2023 Category: Cardiology Authors: R. Lin, A. Jeffries, A. Jolley, M. Stokes Source Type: research

Have MRAs Gone MIA in Queensland?
This study aimed to review the prescription rates of MRAs and other guideline-based therapies in HFrEF patients in Queensland at the time of hospital discharge. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - July 1, 2023 Category: Cardiology Authors: J. Millhouse, S. Sarvananda Source Type: research

Heart Failure and Cognitive Impairment: Is it a Causal Relationship?
This study sought to determine the relationship between subclinical cardiac function and cognitive function. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - July 1, 2023 Category: Cardiology Authors: Q. Huynh, T. Marwick Source Type: research

Heart Failure Rehab Reduces Readmissions and Improves Quality of Life
Heart failure (HF) patients often have limited exercise capacity due to dyspnoea and fatigue. Despite the availability of effective treatment, HF is associated with poor quality of life (QOL), high morbidity and mortality. M āori are twice as likely to die and four times more likely to be hospitalised for HF. Heart failure hospitalisations cost an estimated 2% to New Zealand’s health system. Supervised exercise programs are recommended for HF patients. However, establishing and maintaining these programs are challeng ing due to fiscal, facility, and staffing constraints. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - July 1, 2023 Category: Cardiology Authors: K. Dyson, D. Kaur, E. Hall, J. Lowrey Source Type: research

Heart Failure Therapy Optimisation in a Patient With Significant Mitral Regurgitation With Transeptal Mitral Valve Replacement, HighLife Valve, and 3-Years Follow-Up
Heart failure therapy optimisation with significantly improved outcomes has been shown with transcatheter edge-to-edge repair (TEER) in patients with persistent and significant residual mitral regurgitation (MR) despite full medical and device therapy. The feasibility of transcatheter transeptal mitral valve replacement (TSMVR) for these patients is unknown. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - July 1, 2023 Category: Cardiology Authors: W. Yeow Source Type: research

Impact of a Multi-Disciplinary Heart Failure Team in a Regional Hospital
This study investigated the impact of a multidisciplinary team on the prescribing of “the four pillars” of Heart Failure Guideline-Directed Medical Therapy, iron infusion administration, length of stay, and readmission rates for patients with heart failure with reduced ejection fraction (HFrEF). (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - July 1, 2023 Category: Cardiology Authors: G. Birdsey, R. Stornebrink, K. Rankin, J. Amerena, A. McKinnon Source Type: research

Impact of Atrial Fibrillation Burden on Cardiovascular Outcomes in Patients With Heart Failure With Reduced Ejection Fraction
This study sought to assess the impact of AF burden on cardiovascular outcomes in this population. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - July 1, 2023 Category: Cardiology Authors: H. Chen, A. Bhat, A. Drescher, G. Gan, T. Tan Source Type: research

Impact of Hyperkalaemia on the Management of Heart Failure Patients With Reduced Ejection Fraction Within a Multi-Centre Heart Failure Clinic
This study investigated the prevalence of hyperkalaemia and its impact on medical therapy and outcomes in patients with HFREF managed in a multi-centre HF clinic service. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - July 1, 2023 Category: Cardiology Authors: L. Kearney, A. Williamson, E. Chowdhury, M. Duong, J. McGillion, N. Schwarz, D. Eccleston Source Type: research

Impact of Pacing Burden on Cardiovascular Outcomes in Patients With Heart Failure With Reduced Ejection Fraction
This study sought to assess the impact of high RVP burden on cardiovascular outcomes in a stable population with HFrEF. (Source: Heart, Lung and Circulation)
Source: Heart, Lung and Circulation - July 1, 2023 Category: Cardiology Authors: H. Chen, A. Bhat, A. Drescher, G. Gan, A. Kanthan, T. Tan Source Type: research